BMJ  2006;332:321 (11 February), doi:10.1136/bmj.332.7537.321

News

Inhaled insulin is approved in Europe and United States

Jeanne Lenzer

New York

The first 150 words of the full text of this article appear below.

An inhaled form of human insulin, Exubera, has been approved in Europe and the United States for the treatment of type 1 and 2 diabetes in adults. The drug, to be marketed jointly by Pfizer and Sanofi-Aventis, was hailed by the US Food and Drug Administration as the "first new insulin delivery option introduced since the discovery of insulin in the 1920s."

Both the FDA and the European Agency for the Evaluation of Medicinal Products have specified that the drug, which will not be available for several months, is contraindicated in smokers and in patients who have smoked in the preceding six months. It is "not recommended" in patients with asthma, bronchitis, or emphysema.

The European agency has also specified that Exubera is indicated only for "adult patients with type 2 diabetes mellitus not adequately controlled with oral antidiabetic agents and requiring insulin therapy" or for patients with type 1 . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Approval of inhaled insulin in Europe and United States
Bruce Charlesworth
BMJ 2006 332: 730. [Extract] [Full Text]

A time for courage
Fiona Godlee
BMJ 2006 332: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Wolzt, M., de la Pena, A., Berclaz, P.-Y., Tibaldi, F. S., Gates, J. R., Muchmore, D. B. (2008). AIR Inhaled Insulin Versus Subcutaneous Insulin: Pharmacokinetics, glucodynamics, and pulmonary function in asthma. Diabetes Care 31: 735-740 [Abstract] [Full text]  
  • Schaafsma, D., McNeill, K. D., Stelmack, G. L., Gosens, R., Baarsma, H. A., Dekkers, B. G. J., Frohwerk, E., Penninks, J.-M., Sharma, P., Ens, K. M., Nelemans, S. A., Zaagsma, J., Halayko, A. J., Meurs, H. (2007). Insulin increases the expression of contractile phenotypic markers in airway smooth muscle. Am. J. Physiol. Cell Physiol. 293: C429-C439 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Inhaled insulin is approved in Europe and United States
Bruce Charlesworth
bmj.com, 14 Mar 2006 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ